NeuroOne Medical Technologies Corporation Depreciation
NeuroOne Medical Technologies Corporation (NMTC) reported Depreciation of $41.42 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation depreciation for the quarter ending 2026-06-30 was $41.42K, a 32.11% decline year-over-year.
- NeuroOne Medical Technologies Corporation depreciation for the quarter ending 2026-03-31 was $54.45K, a 9.33% decline year-over-year.
- NeuroOne Medical Technologies Corporation depreciation for the quarter ending 2025-12-31 was $59.95K, a 0.67% increase year-over-year.
- NeuroOne Medical Technologies Corporation depreciation for the quarter ending 2025-09-30 was $58.74K, a 0.34% increase year-over-year.
- NeuroOne Medical Technologies Corporation depreciation for fiscal 2025 was $239.36K, a 6.63% increase from fiscal 2024.
- NeuroOne Medical Technologies Corporation depreciation for fiscal 2024 was $224.48K, a 26.86% increase from fiscal 2023.
- NeuroOne Medical Technologies Corporation depreciation for fiscal 2023 was $176.95K, a 83.74% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation depreciation for fiscal 2022 was $96.31K, a 64.82% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $41.42K 10-Q · filed 2026-08-13 | $95.87K derived: sum of 2 quarters · filed 2026-08-13 | $155.82K 10-Q · filed 2026-08-13 | $214.56K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $54.45K 10-Q/A · filed 2026-06-12 | $114.39K 10-Q/A · filed 2026-06-12 | $173.14K derived: sum of 3 quarters · filed 2026-06-12 | $234.16K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $59.95K 10-Q · filed 2026-02-17 | $118.69K derived: sum of 2 quarters · filed 2026-02-17 | $179.71K derived: sum of 3 quarters · filed 2026-08-13 | $239.76K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $58.74K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $119.76K derived: sum of 2 quarters · filed 2026-08-13 | $179.81K derived: sum of 3 quarters · filed 2026-08-13 | $239.36K 10-K · filed 2025-12-17 |
| 2025-06-30 | $61.02K 10-Q · filed 2026-08-13 | $121.07K derived: sum of 2 quarters · filed 2026-08-13 | $180.62K 10-Q · filed 2026-08-13 | $239.17K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $60.05K 10-Q/A · filed 2026-06-12 | $119.60K 10-Q/A · filed 2026-06-12 | $178.15K derived: sum of 3 quarters · filed 2026-06-12 | $235.68K derived: sum of 4 quarters · filed 2026-06-12 |
| 2024-12-31 | $59.55K 10-Q · filed 2026-02-17 | $118.10K derived: sum of 2 quarters · filed 2026-02-17 | $175.63K derived: sum of 3 quarters · filed 2026-02-17 | $230.95K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $58.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $116.08K derived: sum of 2 quarters · filed 2025-12-17 | $171.40K derived: sum of 3 quarters · filed 2025-12-17 | $224.48K 10-K · filed 2025-12-17 |
| 2024-06-30 | $57.53K 10-Q · filed 2025-08-14 | $112.85K derived: sum of 2 quarters · filed 2025-08-14 | $165.93K 10-Q · filed 2025-08-14 | $222.86K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $55.32K 10-Q · filed 2025-05-13 | $108.40K 10-Q · filed 2025-05-13 | $165.33K derived: sum of 3 quarters · filed 2025-05-13 | $216.71K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $53.08K 10-Q · filed 2025-02-12 | $110.01K derived: sum of 2 quarters · filed 2025-02-12 | $161.39K derived: sum of 3 quarters · filed 2025-02-12 | $199.72K derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $56.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $108.31K derived: sum of 2 quarters · filed 2024-12-17 | $146.64K derived: sum of 3 quarters · filed 2024-12-17 | $176.95K 10-K · filed 2024-12-17 |
| 2023-06-30 | $51.38K 10-Q · filed 2024-08-14 | $89.71K derived: sum of 2 quarters · filed 2024-08-14 | $120.02K 10-Q · filed 2024-08-14 | $147.86K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $38.33K 10-Q · filed 2024-05-14 | $68.64K 10-Q · filed 2024-05-14 | $96.48K derived: sum of 3 quarters · filed 2024-05-14 | $122.41K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $30.31K 10-Q · filed 2024-02-13 | $58.15K derived: sum of 2 quarters · filed 2024-02-13 | $84.08K derived: sum of 3 quarters · filed 2024-02-13 | $107.03K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $27.84K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $53.77K derived: sum of 2 quarters · filed 2023-12-15 | $76.72K derived: sum of 3 quarters · filed 2023-12-15 | $96.31K 10-K · filed 2023-12-15 |
| 2022-06-30 | $25.93K 10-Q · filed 2023-08-14 | $48.88K derived: sum of 2 quarters · filed 2023-08-14 | $68.46K 10-Q · filed 2023-08-14 | $85.25K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $22.95K 10-Q · filed 2023-05-12 | $42.53K 10-Q · filed 2023-05-12 | $59.32K derived: sum of 3 quarters · filed 2023-05-12 | $74.09K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $19.58K 10-Q · filed 2023-02-13 | $36.37K derived: sum of 2 quarters · filed 2023-02-13 | $51.14K derived: sum of 3 quarters · filed 2023-02-13 | $64.86K derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-09-30 | $16.78K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $31.56K derived: sum of 2 quarters · filed 2022-12-22 | $45.27K derived: sum of 3 quarters · filed 2022-12-22 | $58.43K 10-K · filed 2022-12-22 |
| 2021-06-30 | $14.78K 10-Q · filed 2022-08-11 | $28.49K derived: sum of 2 quarters · filed 2022-08-11 | $41.65K 10-Q · filed 2022-08-11 | $49.84K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $13.71K 10-Q · filed 2022-05-12 | $26.87K 10-Q · filed 2022-05-12 | $35.06K derived: sum of 3 quarters · filed 2022-05-31 | $42.36K derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-12-31 | $13.16K 10-Q · filed 2022-02-14 | $21.35K derived: sum of 2 quarters · filed 2022-05-31 | $28.64K derived: sum of 3 quarters · filed 2022-05-31 | $34.13K derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-09-30 | $8.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-31 | $15.49K derived: sum of 2 quarters · filed 2022-05-31 | $20.98K derived: sum of 3 quarters · filed 2022-05-31 | $25.29K 10-K/A · filed 2022-05-31 |
| 2020-06-30 | $7.30K 10-Q · filed 2021-08-13 | $12.79K derived: sum of 2 quarters · filed 2021-08-13 | $17.11K 10-Q · filed 2021-08-13 | $22.74K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $5.49K 10-Q · filed 2021-05-14 | $9.81K 10-Q · filed 2021-05-14 | $15.44K derived: sum of 3 quarters · filed 2021-05-14 | $16.13K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $4.32K 10-Q · filed 2021-02-16 | $9.95K derived: sum of 2 quarters · filed 2021-02-16 | $10.64K derived: sum of 3 quarters · filed 2021-02-16 | $10.64K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $5.63K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-09 | $6.33K derived: sum of 2 quarters · filed 2020-12-09 | $6.33K derived: sum of 3 quarters · filed 2020-12-09 | $6.33K 10-K · filed 2020-12-09 |
| 2019-06-30 | $694.00 10-Q · filed 2020-08-13 | $694.00 derived: sum of 2 quarters · filed 2020-08-13 | $694.00 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | $0.00 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |